# Fecal Microbiome Transplantation in Cirrhosis: Trial in Patients With Decompensated Cirrhosis

> **NCT06533852** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Consorcio Centro de Investigación Biomédica en Red (CIBER)** · enrollment: 190 (estimated)

## Conditions studied

- Decompensated Cirrhosis

## Interventions

- **DRUG:** Fecal Microbiome Transplantation (FMT)
- **OTHER:** FMT Placebo

## Key facts

- **NCT ID:** NCT06533852
- **Lead sponsor:** Consorcio Centro de Investigación Biomédica en Red (CIBER)
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12
- **Primary completion:** 2028-05
- **Final completion:** 2028-05
- **Target enrollment:** 190 (ESTIMATED)
- **Last updated:** 2024-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06533852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06533852, "Fecal Microbiome Transplantation in Cirrhosis: Trial in Patients With Decompensated Cirrhosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06533852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*